FundingWatcher
Home / Startups / By venture fund / SOSV SF & NY (Fka IndieBio) portfolio companies

SOSV SF & NY (Fka IndieBio) portfolio companies

Updated 16 Nov 2026

https://sosv.com/

SOSV SF & NY (Fka IndieBio) portfolio companies
One-time CSV
  • 57 funded companies, 51 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-investor-synbio-axlr8r.csv57 rows × 18 columns
CompanyCityLast roundAmountDate
Prolific MachinesEmeryvilleSeries B$50.0M2026-10-14
heXem bioNew YorkSeed$10.4M2026-09-15
Mendel.aiSan JoseSeries B$40.0M2022-03-25
RybodynSan DiegoSeed$1.3M2026-07-23
AvaloDurhamSeries A$11.0M2025-03-06
BioSapienSan DiegoSeed$8.0M2024-12-13
BioFluffParisSeed$2.5M2026-09-02
KonikuSan RafaelSeries A$37.0M2021-12-17

8 rows of the CSV in 5 of its 18 columns.

57
Startups
$557.6M
Total raised
17
Funded in the last 12 months
$99.3M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

24 of 57
24 rows
Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
Prolific Machines Prolific Machines develops light-controlled gene expression systems for producing therapeutics. Artificial intelligence Emeryville, United States Series B $50.0M 2026-10-14 $147.0M SOSV, Mayfield Fund, SOSV SF & NY (Fka IndieBio) +2 51 to 100 2020
heXem bio HexemBio develops a synthetic human Yolk Sac platform to rejuvenate blood stem cells and extend healthy lifespan. Biotech New York, United States Seed $10.4M 2026-09-15 $10.4M SOSV, SOSV SF & NY (Fka IndieBio) 1 to 10 2024
BryoSphere BryoSphere manufactures specialty chemicals using moss plants and biotechnology methods. Biotech Burnaby, Canada Angel $29K 2026-09-08 $29K SOSV, SOSV SF & NY (Fka IndieBio) 1 to 10 2022
BioFluff BioFluff creates plant-based fur, shearling, and plush for the fashion, interior, and toy industries. Biotech Paris, France Seed $2.5M 2026-09-02 $3.2M SOSV, SOSV SF & NY (Fka IndieBio), Joyance Partners +1 1 to 10 2022
Rybodyn Rybodyn develops therapeutics that train the immune system to detect and eradicate cancer. Biotech San Diego, United States Seed $1.3M 2026-07-23 $15.3M SOSV, SOSV SF & NY (Fka IndieBio) 11 to 50 2022
Fermeate Fermeate provides photomolecular fermentation technology that makes biomanufacturing more sustainable and efficient. Biotech San Francisco, United States Seed $2.5M 2026-04-27 $2.5M SOSV, SOSV SF & NY (Fka IndieBio) 1 to 10 2024
TippingPoint Biosciences TippingPoint Biosciences develops therapeutics that target genome packaging states in diseases such as cancer. Biotech San Francisco, United States Seed $4.5M 2026-03-31 $4.5M SOSV, SOSV SF & NY (Fka IndieBio) 1 to 10 2022
BioLattice BioLattice develops tissue healing solutions. Biotech Philadelphia, United States Seed $575K 2026-03-30 $585K SOSV, SOSV SF & NY (Fka IndieBio), Startup302 1 to 10 2017
FluoSphera FluoSphera develops drugs. Biotech Geneva, Switzerland Seed $1.4M 2026-01-12 $3.9M SOSV, SOSV SF & NY (Fka IndieBio), FONGIT Innovation Fund +2 1 to 10 2021
Cayuga Biotech Cayuga Biotech develops hemostatic drugs and devices for treating bleeding episodes. Biotech Bridgewater, United States Seed $5.0M 2025-12-11 $8.2M SOSV, SOSV SF & NY (Fka IndieBio) 1 to 10 2015
OncoPrecision OncoPrecision develops patient-centric therapeutic antibodies. Biotech New York, United States Seed $4.5M 2025-11-24 $11.1M SOSV, SOSV SF & NY (Fka IndieBio), GRID EXPONENTIAL +2 11 to 50 2020
Helex Helex works on making gene editing safer. Biotech New York, United States Seed $3.5M 2025-10-30 $4.6M SOSV, SOSV SF & NY (Fka IndieBio) 11 to 50 2021
Avalo Avalo applies AI and evolutionary methods to plant biotechnology for a more sustainable food system. Artificial intelligence Durham, United States Series A $11.0M 2025-03-06 $14.9M SOSV, SOSV SF & NY (Fka IndieBio), Alexandria Venture Investments +2 11 to 50 2020
BioSapien BioSapien is a biotech startup that provides a drug delivery platform for cancer treatment. Biotech San Diego, United States Seed $8.0M 2024-12-13 $45.1M SOSV, National Science Foundation, SOSV SF & NY (Fka IndieBio) +2 1 to 10 2018
Ceragen Ceragen is a biotechnology company that boosts crop yields through plant microbiome engineering. Biotech Kitchener, Canada Seed $2.0M 2024-07-16 SOSV, SOSV SF & NY (Fka IndieBio), 1517 Fund +1 1 to 10 2021
Xias Bio Xias Bio produces soluble, active recombinant proteins for formulators to improve gel and film formation. Biotech Glasgow, United Kingdom Seed $4.8M 2024-05-01 SOSV, SOSV SF & NY (Fka IndieBio) 11 to 50 2020
Gozen Bioworks Gozen Bioworks is a multidisciplinary materials science and design company. Biotech Istanbul, Turkey Seed $3.3M 2023-10-25 SOSV, SOSV SF & NY (Fka IndieBio), Happiness Capital +1 1 to 10 2020
Veloz Bio Veloz Bio uses molecular farming to produce animal-free and alternative proteins. Biotech Monterrey, Mexico Seed $4.0M 2023-08-31 SOSV, SOSV SF & NY (Fka IndieBio), Santatera Capital 1 to 10 2021
NotCo Unicorn NotCo is a food tech company that uses artificial intelligence to make food from plants. Artificial intelligence Santiago, Chile Series D $70.0M 2022-12-12 SOSV, General Catalyst, SOSV SF & NY (Fka IndieBio) +2 101 to 250 2015
Mendel.ai Mendel.ai combines machine precision and human judgment to advance clinical research. Artificial intelligence San Jose, United States Series B $40.0M 2022-03-25 $65.4M SOSV, DCM Ventures, SOSV SF & NY (Fka IndieBio) +2 101 to 250 2017
Koniku Koniku combines synthetic biology with silicon to build machines that detect smells. Artificial intelligence San Rafael, United States Series A $37.0M 2021-12-17 $49.2M SOSV, SoftBank Vision Fund, SOSV SF & NY (Fka IndieBio) +1 11 to 50 2015
Quartolio Quartolio uses autonomous discovery to analyze millions of scientific documents in real time. Artificial intelligence New York, United States Seed $34K 2021-11-18 $154K Techstars, SOSV, MassChallenge +2 1 to 10 2016
Biomage Biomage provides single-cell analysis tools for life sciences research. Biotech Glasgow, United Kingdom Seed $850K 2020-12-08 SOSV, SOSV SF & NY (Fka IndieBio), Techstart Ventures +2 11 to 50 2019
aBioBot aBioBot helps bio scientists make discoveries faster by shortening research timelines. Biotech Dublin, United States Pre-seed $50K 2015-02-03 SOSV, SOSV SF & NY (Fka IndieBio) 1 to 10 2015

Table 1. SOSV SF & NY (Fka IndieBio) portfolio companies: the 24 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 57.

Largest rounds

Last 12 months
10 rows
# Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
1 Prolific Machines Prolific Machines develops light-controlled gene expression systems for producing therapeutics. Artificial intelligence Emeryville, United States Series B $50.0M 2026-10-14 $147.0M SOSV, Mayfield Fund, SOSV SF & NY (Fka IndieBio) +2 51 to 100 2020
2 heXem bio HexemBio develops a synthetic human Yolk Sac platform to rejuvenate blood stem cells and extend healthy lifespan. Biotech New York, United States Seed $10.4M 2026-09-15 $10.4M SOSV, SOSV SF & NY (Fka IndieBio) 1 to 10 2024
3 Cayuga Biotech Cayuga Biotech develops hemostatic drugs and devices for treating bleeding episodes. Biotech Bridgewater, United States Seed $5.0M 2025-12-11 $8.2M SOSV, SOSV SF & NY (Fka IndieBio) 1 to 10 2015
4 OncoPrecision OncoPrecision develops patient-centric therapeutic antibodies. Biotech New York, United States Seed $4.5M 2025-11-24 $11.1M SOSV, SOSV SF & NY (Fka IndieBio), GRID EXPONENTIAL +2 11 to 50 2020
5 TippingPoint Biosciences TippingPoint Biosciences develops therapeutics that target genome packaging states in diseases such as cancer. Biotech San Francisco, United States Seed $4.5M 2026-03-31 $4.5M SOSV, SOSV SF & NY (Fka IndieBio) 1 to 10 2022
6 Fermeate Fermeate provides photomolecular fermentation technology that makes biomanufacturing more sustainable and efficient. Biotech San Francisco, United States Seed $2.5M 2026-04-27 $2.5M SOSV, SOSV SF & NY (Fka IndieBio) 1 to 10 2024
7 BioFluff BioFluff creates plant-based fur, shearling, and plush for the fashion, interior, and toy industries. Biotech Paris, France Seed $2.5M 2026-09-02 $3.2M SOSV, SOSV SF & NY (Fka IndieBio), Joyance Partners +1 1 to 10 2022
8 FluoSphera FluoSphera develops drugs. Biotech Geneva, Switzerland Seed $1.4M 2026-01-12 $3.9M SOSV, SOSV SF & NY (Fka IndieBio), FONGIT Innovation Fund +2 1 to 10 2021
9 Rybodyn Rybodyn develops therapeutics that train the immune system to detect and eradicate cancer. Biotech San Diego, United States Seed $1.3M 2026-07-23 $15.3M SOSV, SOSV SF & NY (Fka IndieBio) 11 to 50 2022
10 BioLattice BioLattice develops tissue healing solutions. Biotech Philadelphia, United States Seed $575K 2026-03-30 $585K SOSV, SOSV SF & NY (Fka IndieBio), Startup302 1 to 10 2017

Table 2. SOSV SF & NY (Fka IndieBio) portfolio companies: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 National Science Foundation Entrepreneurship program Alexandria, United States 3 5%
2 MassChallenge Switzerland Startup accelerator Renens, Switzerland 3 5%
3 Plug and Play Startup accelerator Sunnyvale, United States 2 4% 1 Prellis Biologics
4 Genesis Consortium Venture capital firm Princeton, United States 2 4%
5 Techstars Startup accelerator New York, United States 2 4%
6 GRID EXPONENTIAL Startup accelerator Buenos Aires, Argentina 2 4% 1 OncoPrecision
7 Breakthrough Energy Ventures Venture capital firm Paris, France 1 2% 1 Prolific Machines
8 Breyer Capital Venture capital firm Menlo Park, United States 1 2% 1 Prolific Machines
9 Mayfield Fund Venture capital firm Menlo Park, United States 1 2% 1 Prolific Machines
10 Cantos Micro VC fund San Francisco, United States 1 2% 1 Prellis Biologics
11 Khosla Ventures Venture capital firm Menlo Park, United States 1 2% 1 Prellis Biologics
12 DCM Ventures Venture capital firm Menlo Park, United States 1 2%
13 BootstrapLabs Venture capital firm San Francisco, United States 1 2%
14 Oak HC/FT Private equity firm Stamford, United States 1 2%

Table 3. SOSV SF & NY (Fka IndieBio) portfolio companies: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Biotech 39 68% $499.5M
Health care 25 44% $492.7M
Software 15 26% $299.6M
Artificial intelligence 9 16% $280.6M
Hardware 3 5% $19.0M
Energy 1 2% $750K

Table 4. SOSV SF & NY (Fka IndieBio) portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Pre-seed 6 11% $200K
Seed 41 72% $3.5M
Series A 4 7% $11.0M
Series B 4 7% $40.0M
Series C 1 2%
Series D+ 1 2% $70.0M

Table 5. SOSV SF & NY (Fka IndieBio) portfolio companies by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Countries

CountriesCompaniesShare
United States 43 75%
United Kingdom 3 5%
Mexico 2 4%
Canada 2 4%
France 1 2%
Switzerland 1 2%
Chile 1 2%
Turkey 1 2%
Estonia 1 2%
Argentina 1 2%

Table 6. SOSV SF & NY (Fka IndieBio) portfolio companies by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
New York 9 16%
San Francisco 9 16%
San Diego 3 5%
San Rafael 2 4%
Glasgow 2 4%
Emeryville 1 2%
Berkeley 1 2%
San Jose 1 2%
Durham 1 2%
Paris 1 2%
Davis 1 2%
Geneva 1 2%

Table 7. SOSV SF & NY (Fka IndieBio) portfolio companies by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
October 2026 1 6% $50.0M
September 2026 4 24% $12.9M
August 2026 1 6%
July 2026 1 6% $1.3M
May 2026 2 12%
April 2026 1 6% $2.5M
March 2026 2 12% $5.1M
January 2026 2 12% $7.4M
December 2025 2 12% $15.5M
November 2025 1 6% $4.5M

Table 8. SOSV SF & NY (Fka IndieBio) portfolio companies: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 14 25% $79.3M
2025 10 18% $39.7M
2024 16 28% $24.6M
2023 7 12% $26.5M
2022 4 7% $110.0M
2021 3 5% $37.0M

Table 9. SOSV SF & NY (Fka IndieBio) portfolio companies by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 12 21%
2020 to 2022 24 42%
2015 to 2019 20 35%
Before 2010 1 2%

Table 10. SOSV SF & NY (Fka IndieBio) portfolio companies by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 38 67%
11 to 50 15 26%
51 to 100 1 2%
101 to 250 2 4%
251 to 500 1 2%

Table 11. SOSV SF & NY (Fka IndieBio) portfolio companies by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many SOSV SF & NY (Fka IndieBio) portfolio companies are on the list?
57, in the file dated 16 November 2026. 17 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 57 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

SOSV SF & NY (Fka IndieBio) portfolio companies: 57 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Portfolio companies by country

Portfolio companies by city

Other venture fund portfolios

Cite: FundingWatcher, 57 startups, 16 November 2026. https://fundingwatcher.com/startups/investor/synbio-axlr8r/